Aims: The purposes of this study were to describe the visual outcome of highly myopic eyes undergoing cataract surgery, to investigate associated risk factors for poor postoperative vision, and to assess postoperative complication frequency among the prevalent myopic Taiwanese population. Methods: We conducted a retrospective, noncomparative case series study at the Department of Ophthalmology, Zhongxing Branch, Taipei City Hospital, Taiwan. High myopia was defined as axial length of 26.0 mm. Main study outcomes were visual acuity for the initial 6-month postoperative period (including visual acuities and improvement of postoperative vision), and postoperative complications (including subsequent cataract formation and postoperative retinal detachment). Results: Fifty-two highly myopic eyes were registered between January 2002 and December 2004. Mean follow-up interval was 43.3 ± 20.2 weeks (range 25–103). Thirty-two eyes (61.5%) had good postoperative visual improvement (≧4 line Snellen chart). Thirty-seven eyes (71.2%) achieved good postoperative vision (20/40 or better). Fifteen eyes (28.8%) demonstrated poor postoperative vision. Pre-existing maculopathy was an independent risk factor for failure to achieve good postoperative vision (odds ratio, OR, 6.84, 95% confidence interval, CI: 1.12–41.8) and improvement (OR 16.1, 95% CI: 2.2–119.9). Diabetic history was considered another independent risk factor for poor postoperative vision (OR 15.6, 95% CI: 0.97–267.6). Six eyes (11.5%) developed subsequent posterior capsular opacification requiring Nd:YAG laser capsulotomy. Two eyes (3.8%) developed retinal detachment during follow-up. Conclusions: Most of highly myopic eyes achieved good visual improvement and good postoperative visual acuity after cataract surgery. Pre-existing maculopathy was an independent risk factor of postoperative visual improvement and status. It is crucial to examine retinal status prior to cataract surgery to prevent poor vision improvement, poor postoperative vision, or retinal complications.

Keywords:
Cataract surgery, High myopia, Nd:YAG laser, Retinal detachment, Visual acuity
1.
Lin LL, Shih YF, Hsiao CK, Chen CJ: Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore 2004;33:27–33.
2.
Cheng CY, Hsu WM, Liu JH, Tsai SY, Chou P: Refractive errors in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci 2003;44:4630–4638.
3.
Tsai CY, Woung LC, Chou P, et al: The current status of visual disability in the elderly population of Taiwan. Jpn J Ophthalmol 2005;49:166–172.
4.
Modarres M, Parvaresh MM, Hashemi M, Peyman GA: Inadvertent globe perforation during retrobulbar injection in high myopes. Int Ophthalmol 1997–98; 21:179–185.
5.
Lois N, Wong D: Pseudophakic retinal detachment. Surv Ophthalmol 2003;48:467–487.
6.
Fan DS, Lam DS, Li KK: Retinal complications after cataract extraction in patients with high myopia. Ophthalmology 1999;106:688–691.
7.
Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P: Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology 2003;110:1089–1095.
8.
Panchapakesan J, Rochtchina E, Mitchell P: Myopic refractive shift caused by incident cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003;10:241–247.
9.
Pesudovs K, Elliott DB: Refractive error changes in cortical, nuclear, and posterior subcapsular cataracts. Br J Ophthalmol 2003;87:964–967.
10.
Chen SN, Lin KK, Chao AN, Kuo YH, Ho JD: Nuclear sclerotic cataract in young patients in Taiwan. J Cataract Refract Surg 2003;29:983–988.
11.
Grossniklaus HE, Green WR: Pathologic findings in pathologic myopia. Retina 1992;12:127–133.
12.
Moria H, Funatra M, Tokoro T: A clinical study of development of posterior vitreous detachment in high myopia. Retina 1995;15:117–124.
13.
Pierro L, Camesasca FI, Mischi M, Brancato R: Peripheral retinal changes and axial myopia. Retina 1992;12:12–17.
14.
Percival SP: Redefinition of high myopia: the relationship of axial length measurement to myopic pathology and its relevance to cataract surgery. Dev Ophthalmol 1987;14:42–46.
15.
Ogata N, Imaizumi M, Miyashiro M, Arichi M, Matsuoka M, Ando A, Matsumura M: Low levels of pigment epithelium derived factor in highly myopic eyes with chorioretinal atrophy. Am J Ophthalmol 2005;140:937–939.
16.
Fang YT, Chien LN, Ng YY, Chu HF, Chen WM, Cheng CY, Wu SC: Association of hospital and surgeon operation volume with the incidence of postoperative endophthalmitis: Taiwan experience. Eye 2006;20:900–907.
17.
Lyle WA, Jin GJ: Phacoemulsification with intraocular lens implantation in high myopia. J Cataract Refract Surg 1996;22:238–242.
18.
Ku WC, Chuang LH, Lai CC: Cataract extraction in high myopic eyes. Chang Gung Med J 2002;25:315–320.
19.
Squirrell D, Bhola R, Bush J, Winder S, Talbot JF: A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetics. Br J Ophthalmol 2002;86:565–571.
20.
Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A: Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular edema. Graefes Ach Clin Exp Ophthalmol 2002;240:735–738.
21.
Aslam TM, Devlin H, Dhillon B: Use of Nd YAG laser capsulotomy. Surv Ophthalmol 2003;48:594–612.
22.
Guell JL, Rodriguez-Arenas AF, Gris O, Malecaze F, Velasco F: Phacoemulsification of the crystalline lens and implantation of an intraocular lens for the correction of moderate and high myopia: four-year follow-up. J Cataract Refract Surg 2003;29:34–38.
23.
Sheu SJ, Ger LP, Chen JF: Risk factors for retinal detachment after cataract surgery in southern Taiwan. J Chin Med Assoc 2005;68:321–326.
24.
Ripandelli G, Scassa C, Parisi V, Gazzaniga D, D’Amico DJ, Stirpe M: Cataract surgery as a risk factor for retinal detachment in very highly myopic eyes. Ophthalmology 2003;110:2355–2361.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.